1,3-Dioxane-Linked Bacterial Topoisomerase Inhibitors with Enhanced Antibacterial Activity and Reduced hERG...

Area of Science:

• Medicinal Chemistry
• Microbiology
• Pharmacology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat, necessitating the development of novel therapeutic agents.
• Inhibitors of bacterial DNA gyrase and topoisomerase IV (TopoIV) represent a promising class of antibiotics against MRSA.
• Previous research identified dioxane-linked derivatives as potential candidates, but further optimization is needed.

Purpose of the Study:

• To investigate a series of dioxane-linked derivatives for enhanced antistaphylococcal activity.
• To evaluate the safety profile of these compounds, specifically focusing on hERG channel inhibition.
• To assess the inhibitory potential of analogues against the secondary target, TopoIV.

Main Methods:

• Synthesis and chemical characterization of novel dioxane-linked compounds.
• In vitro evaluation of antistaphylococcal activity against MRSA strains.
• Assessment of hERG channel inhibition using electrophysiological methods.
• Enzyme inhibition assays to determine TopoIV activity.

Main Results:

• A series of dioxane-linked derivatives demonstrated improved activity against MRSA.
• Several analogues exhibited reduced inhibition of the hERG channel, indicating a better safety profile.
• A subset of these compounds showed enhanced inhibition of the secondary target, TopoIV.

Conclusions:

• Dioxane-linked derivatives represent a promising scaffold for developing new anti-MRSA therapies.
• Optimization has led to compounds with improved efficacy and reduced cardiotoxicity.
• Further development of these TopoIV inhibitors could provide valuable new treatment options for MRSA infections.